polifeprosan

Small moleculeexperimental

Clinical trial activity

8 trials · 9 clinical orgs · 0 marketing orgs

Phase 1
5
Phase 2
4
Phase 3
0
Phase 4
0

Earliest trial started Jan 1, 1998 (NCT00003467)

Timeline

1990s

  1. Jan 1, 1998

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 1998

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
Yes

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • polifeprosan
  • polifeprosan
  • polifeprosan
  • polifeprosan 20
  • polifeprosan 20

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00919737Phase 1/Phase 2 (Phase 2)Jun 1, 2009Nobel Pharmaceuticals, Saitama Medical University
NCT00814593Phase 2Nov 1, 2008Caladrius Biosciences
NCT00045721Phase 1Mar 1, 2003National Cancer Institute (NCI), Pediatric Brain Tumor Consortium, University of Pittsburgh
NCT00003878Phase 2Apr 1, 2002Johns Hopkins University, National Cancer Institute (NCI)
NCT00004892Phase 1Apr 1, 2000Johns Hopkins University, National Cancer Institute (NCI)
NCT00003876Phase 1Apr 1, 1999University of Cincinnati
NCT00003463Phase 1Jul 1, 1998Duke University, National Cancer Institute (NCI)
NCT00003467Phase 2Jan 1, 1998Duke University, National Cancer Institute (NCI)
Showing 8 of 8 trials
Page 1 / 1

Organizations

Research & Development (9)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
National Cancer Institute (NCI)Government5221998
Duke UniversityAcademic/Hospital2221998
Johns Hopkins UniversityAcademic/Hospital2022000
Caladrius BiosciencesFor profit1112008
Nobel PharmaceuticalsFor profit1112009
Pediatric Brain Tumor ConsortiumAcademic/Hospital1112003
Saitama Medical UniversityAcademic/Hospital1012009
University of CincinnatiAcademic/Hospital1111999
University of PittsburghAcademic/Hospital1012003
9 organizations
Page 1 / 1